Mahesh Karande - Oct 27, 2022 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGA)

Role
President and CEO, Director
Signature
/s/ Barbara Chan as Attorney-in-Fact for Mahesh Karande
Stock symbol
OMGA
Transactions as of
Oct 27, 2022
Transactions value $
$0
Form type
4
Date filed
10/28/2022, 06:43 PM
Previous filing
Mar 11, 2022
Next filing
Mar 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMGA Option (Right to Buy) Award $0 +170K $0.00 170K Oct 27, 2022 Common Stock 170K $5.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and become exercisable as to 25% of the underlying shares on October 27, 2023 and as to 6.25% of the underlying shares upon the Reporting Person's completion of each three full months of continued service to the Issuer thereafter, such that the option will be fully vested and exercisable on October 27, 2026.